Showing results (1-10 of 300) with videos related to

Sort By:
Pageof 30
Expert Opinion on Investigational Drugs|February 21, 2012
Novel targets for VEGF-independent anti-angiogenic drugsMarco Petrillo, Giovanni Scambia, Gabriella Ferrandina
Aesthetic Surgery Journal|October 14, 2017
Lymphatic and Sensory Function of the Upper Limb After Brachioplasty in Post-Bariatric Massive Weight Loss PatientsStefano Gentileschi, Maria Servillo, Gabriella Ferrandina, et al.
Expert Opinion on Therapeutic Targets|June 18, 2009
Targeting CD133 antigen in cancerGabriella Ferrandina, Marco Petrillo, Giuseppina Bonanno, et al.
Expert Opinion on Emerging Drugs|October 22, 2014
Emerging drugs for endometrial cancerGiulia Amadio, Valeria Masciullo, Maria Gabriella Ferrandina, et al.
Diagnostic Pathology|October 4, 2011
Vulvar squamous cell carcinoma with sarcoma-like stroma: a case report and review of the literatureMarco Petrillo, Giacomo Corrado, Arnaldo Carbone, et al.
Nanomedicine (London, England)|November 19, 2014
Cost-effectiveness of gemcitabine versus PEGylated liposomal doxorubicin for recurrent or progressive ovarian cancer: comparing chemotherapy with nanotherapyRita Bosetti, Gabriella Ferrandina, Wim Marneffe, et al.
Diagnostic Pathology|September 4, 2012
Malignant transformation of Madelung's disease in a patient with a coincidental diagnosis of breast cancer: a case reportMaddalena Borriello, Alessandro Lucidi, Arnaldo Carbone, et al.
Critical Reviews in Oncology/Hematology|October 31, 2003
Gemcitabine: current role and future options in the treatment of ovarian cancerErika Fruscella, Daniela Gallo, Gabriella Ferrandina, et al.
World Journal of Surgical Oncology|August 30, 2008
Conservatively treated glassy cell carcinoma of the cervixGabriella Ferrandina, Vanda Salutari, Marco Petrillo, et al.
Gynecologic Oncology|July 30, 2002
Minilaparotomy in early stage endometrial cancer: an alternative to standard and laparoscopic treatmentAnna Fagotti, Gabriella Ferrandina, Romina Longo, et al.
Pageof 30